Keybank National Association Biogen Inc. Transaction History

Keybank National Association

$25.5 Billion
Q3 2024

A detailed history of Keybank National Association transactions in Biogen Inc. stock. As of the latest transaction made, Keybank National Association holds 7,739 shares of BIIB stock, worth $1.17 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

7,739

Previous 7,921 2.3%

Holding current value

$1.17 Million

Previous $1.84 Million 18.3%

% of portfolio

0.01%

Previous 0.01%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$189.07 - $236.8 $34,410 - $43,097	-182 Reduced 2.3%	7,739 $1.5 Million
Q2 2024 Jul 31, 2024	BUY	$190.52 - $236.72 $18,670 - $23,198	98 Added 1.25%	7,921 $1.84 Million
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $533,230 - $673,290	-2,515 Reduced 24.33%	7,823 $1.69 Million
Q4 2023 Feb 13, 2024	SELL	$222.59 - $267.94 $174,065 - $209,529	-782 Reduced 7.03%	10,338 $2.68 Million
Q3 2023 Nov 08, 2023	BUY	$253.3 - $285.89 $18,237 - $20,584	72 Added 0.65%	11,120 $2.86 Million
Q2 2023 Aug 01, 2023	BUY	$275.25 - $318.06 $32,479 - $37,531	118 Added 1.08%	11,048 $3.15 Million
Q1 2023 May 10, 2023	BUY	$256.56 - $292.34 $159,323 - $181,543	621 Added 6.02%	10,930 $3.04 Million
Q4 2022 Jan 31, 2023	BUY	$252.44 - $306.72 $412,739 - $501,487	1,635 Added 18.85%	10,309 $2.85 Million
Q3 2022 Oct 27, 2022	SELL	$194.69 - $268.46 $105,327 - $145,236	-541 Reduced 5.87%	8,674 $2.32 Million
Q2 2022 Aug 08, 2022	BUY	$187.54 - $223.02 $14,815 - $17,618	79 Added 0.86%	9,215 $1.88 Million
Q1 2022 Apr 28, 2022	SELL	$193.77 - $244.14 $130,600 - $164,550	-674 Reduced 6.87%	9,136 $1.92 Million
Q4 2021 Feb 07, 2022	SELL	$223.92 - $287.77 $160,774 - $206,618	-718 Reduced 6.82%	9,810 $2.35 Million
Q3 2021 Nov 08, 2021	SELL	$282.99 - $369.05 $424,485 - $553,575	-1,500 Reduced 12.47%	10,528 $2.98 Million
Q2 2021 Aug 12, 2021	BUY	$259.0 - $414.71 $316,757 - $507,190	1,223 Added 11.32%	12,028 $4.17 Million
Q1 2021 May 07, 2021	SELL	$242.95 - $284.63 $149,657 - $175,332	-616 Reduced 5.39%	10,805 $3.02 Million
Q4 2020 Feb 09, 2021	SELL	$236.26 - $355.63 $390,065 - $587,145	-1,651 Reduced 12.63%	11,421 $2.8 Million
Q3 2020 Oct 29, 2020	SELL	$264.77 - $305.71 $54,013 - $62,364	-204 Reduced 1.54%	13,072 $3.71 Million
Q2 2020 Aug 10, 2020	SELL	$258.66 - $342.55 $130,623 - $172,987	-505 Reduced 3.66%	13,276 $3.55 Million
Q1 2020 May 13, 2020	SELL	$268.85 - $341.04 $22,045 - $27,965	-82 Reduced 0.59%	13,781 $4.36 Million
Q4 2019 Feb 05, 2020	SELL	$220.06 - $304.07 $156,022 - $215,585	-709 Reduced 4.87%	13,863 $4.11 Million
Q3 2019 Nov 04, 2019	SELL	$217.44 - $243.88 $326,812 - $366,551	-1,503 Reduced 9.35%	14,572 $3.39 Million
Q2 2019 Aug 01, 2019	BUY	$219.29 - $241.72 $48,901 - $53,903	223 Added 1.41%	16,075 $3.76 Million
Q1 2019 May 08, 2019	SELL	$216.71 - $338.96 $19,720 - $30,845	-91 Reduced 0.57%	15,852 $3.75 Million
Q4 2018 Jan 30, 2019	BUY	$278.5 - $352.75 $20,330 - $25,750	73 Added 0.46%	15,943 $4.8 Million
Q3 2018 Nov 08, 2018	SELL	$293.51 - $383.83 $246,548 - $322,417	-840 Reduced 5.03%	15,870 $5.61 Million
Q2 2018 Aug 08, 2018	SELL	$257.52 - $306.91 $320,354 - $381,796	-1,244 Reduced 6.93%	16,710 $4.85 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $816,808 - $1.16 Million	3,140 Added 21.2%	17,954 $4.92 Million
Q4 2017 Feb 08, 2018	SELL	$307.64 - $344.58 $207,964 - $232,936	-676 Reduced 4.36%	14,814 $4.72 Million
Q3 2017 Nov 02, 2017	BUY	$281.15 - $329.69 $525,750 - $616,520	1,870 Added 13.73%	15,490 $4.85 Million
Q2 2017 May 14, 2018	SELL	N/A	-805 Reduced 5.58%	13,620 $3.7 Million
Q1 2017 May 14, 2018	SELL	N/A	-633 Reduced 4.2%	14,425 $3.94 Million
Q4 2016 May 14, 2018	BUY	N/A	15,058	15,058 $4.27 Million

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.8B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keybank National Association, based on Form 13F filings with the SEC.

News

Stay updated on Keybank National Association with notifications on news.

Account

Keybank National Association Biogen Inc. Transaction History